OCT 16, 2015 8:56 AM PDT

A Cure for Ebola?

WRITTEN BY: Kerry Evans
This isn’t the first time I’ve written about Ebola (and it probably won’t be the last).  Recently, a number of techniques for quickly diagnosing Ebola have been developed, and could make it to market in the (hopefully near) future.  Until now, however, there has been little progress towards vaccines or therapeutics for the virus.  Researchers at the US Army Medical Research Institute of Infectious Diseases and Gilead Sciences isolated a compound called GS-5734 that cured monkeys of Ebola virus disease (EVD).  
 
GS-5734 is a promising Ebola therapeutic.

Ebola virus causes a devastating hemorrhagic fever in humans and non-human primates, where the average survival rate is about 50%.  Clinicals symptoms include fever, headaches, vomiting, and bleeding, both internal and external.  Death often results from low blood pressure and overall fluid loss.  

GS-5734 is a nucleotide analog that inhibits the viral RNA polymerase, but does not affect host polymerases (an important consideration).  The group first tested the ability of GS-5734 to inhibit Ebola virus replication in human cell culture.  Next, they treated one group of Ebola-infected monkeys with 3 mg/kg of GS-5734, but only 50% of them survived.  They treated a second set of monkeys with a higher dose of the drug, 10 mg/kg, and all of the monkeys survived.  Clinical symptoms of EVD such as excessive bleeding were also reduced.  Although viral load was significantly decreased, it does not appear that the monkeys were “cured” of the virus.

GS-5734 was also effective against other Filoviruses such as Marburg, indicating it could serve as a broad-spectrum anti-viral.  However, the fact that Ebola virus was still detectable in the “cured” monkeys leaves me only cautiously optimistic.      

Check out the following video for information on Ebola gene-silencing technology being developed in Canada by Tekmira.  
 

Sources: ID Week 2015, Medical News Today, Genome Web, Wikipedia
 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
DEC 01, 2019
Genetics & Genomics
DEC 01, 2019
Engineering a Better Viral Delivery System for Gene Therapy
To send gene therapy to diseased cells, scientists have turned to adeno-associated viruses (AAVs) to act as a delivery system....
DEC 20, 2019
Neuroscience
DEC 20, 2019
Are Migraines Caused by Unhealthy Gut Bacteria?
Research is increasingly pointing towards the importance of the gut-brain axis in regulating our health. Not only has the health of our gut bacteria, or mi...
DEC 27, 2019
Microbiology
DEC 27, 2019
Using a Cancer Drug to Fight Antibiotic-Resistant Pathogens
It takes a long time for a drug to be approved for use in humans; repurposing existing drugs is one way to get around that hurdle....
JAN 28, 2020
Immunology
JAN 28, 2020
Infectious Parasite Manipulates the Immune System to Survive
Toxoplasma gondii suppresses the immune system of the hosts it infects – human or otherwise – just enough to survive, thrive, and move on to mo...
FEB 03, 2020
Microbiology
FEB 03, 2020
The Switch Controlling the Stage of a Common Parasite
The parasite Toxoplasma gondii is thought to infect from one-quarter to one-third of the global population....
FEB 08, 2020
Drug Discovery & Development
FEB 08, 2020
Drug Targets Brain-Eating Amoebas
Brain-eating amoebas lead to high rates of mortality as a result of encephalitis. In fact, more than 95% of people who develop the infection will die. Unfo...
Loading Comments...